Xeris Biopharma Holdings, Inc. (XERS) SEC Filings — 2024
12 SEC filings for Xeris Biopharma Holdings, Inc. (XERS) in 2024.
Filings
- Xeris Biopharma Files 8-K on Financials — 8-K · Nov 8, 2024
- Xeris Biopharma Holdings, Inc. 10-Q Filing — 10-Q · Aug 8, 2024
- Xeris Biopharma Names New Directors, CEO Gets New Contract — 8-K · Aug 2, 2024
- Xeris Biopharma CFO Departs; Q2 Revenue Previewed — 8-K · Jul 8, 2024
- Xeris Biopharma Announces Board Changes and Compensation Updates — 8-K · Jun 5, 2024
- Xeris Biopharma Holdings Files Q1 2024 10-Q — 10-Q · May 9, 2024
- Xeris Biopharma Holdings, Inc. Files Definitive Proxy Statement — DEF 14A · Apr 23, 2024
- Xeris Biopharma Holdings, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 6, 2024
- Xeris Biopharma Holdings, Inc. SC 13G Filing — SC 13G · Feb 13, 2024
- Xeris Biopharma Holdings, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Discloses Passive Stake in Xeris Biopharma — SC 13G · Jan 26, 2024
- Xeris Biopharma Files 8-K on Operations & Financials — 8-K · Jan 4, 2024